Clinical Trials Browser

Not yet recruiting × Endometrial Neoplasms × tislelizumab × Clear all

NCT06363708 2024-04-12

Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer

Phase NA Not yet recruiting

Neoplasms, Endometrial Neoplasms